The main manufacturer of vaccines will be Astrazeneca, and buyers – the EU and the USA. It is reported by RBC with reference to the study of the Dyluk University (USA).
In total, the country concluded contracts for the supply of 8.6 billion doses of the coronavirus vaccine. Of these, the share of Astrazeneca amounted to 2.4 billion doses. In second place Pfizer from 1.5 billion doses. The Chinese Sinovac will disperse a circulation of 480 million doses, and the Russian “satellite V” will spread with 303 million doses. At the same time, it is clarified that in 2021, vaccine manufacturers are able to produce a cumulatively about 12 billion doses of vaccines.
Rich countries booked 4.6 billion doses of vaccines, which is 53 percent of all vaccine purchases. The countries with incomes above average account for 17 percent of procurement, almost the same amount (16 percent) ordered countries with an average supply and inconsider below average. The remaining proportion falls on purchases through the mechanism of equal access to COVAX vaccines under the auspices of the UN.
Most of all doses reserved the European Commission on behalf of 27 EU countries – 1.8 billion doses, in second place – the United States from 1.2 billion. At the same time, a number of states ordered vaccines more than necessary. Closes the Troika African Union with contracts for 680 million doses.